The short answer
If you're wondering whether you qualify for Ozempic (or its sibling drugs Wegovy, Mounjaro, or Zepbound), the answer comes down to two things: your BMI and your existing health conditions.
The standard clinical thresholds that most US prescribing providers follow are simple:
- BMI ≥ 30 — qualifies on BMI alone
- BMI 27 to 29.9 — qualifies with at least one weight-related condition
- BMI under 27 — generally does not qualify for weight-management prescribing
That's the framework. The details below explain what each part means, what counts as a qualifying condition, what providers actually look at beyond BMI, and what your options are if you're close but not quite there.
What Ozempic actually is (and isn't)
Ozempic is the brand name for semaglutide, a once-weekly injectable medication originally FDA-approved in 2017 for managing type 2 diabetes. The same active ingredient at higher doses is sold as Wegovy — which is FDA-approved specifically for chronic weight management.
Semaglutide belongs to a class of drugs called GLP-1 receptor agonists (glucagon-like peptide-1). These drugs work by mimicking a hormone your gut naturally releases after eating, which:
- Slows down stomach emptying (you feel full longer)
- Tells your brain you've eaten (reduces appetite and food cravings)
- Increases insulin release after meals (helps blood sugar control)
- Reduces the liver's glucose production
In clinical trials, people taking semaglutide at weight-management doses lost an average of 15% of their body weight over 68 weeks — significantly more than what diet and exercise alone typically achieve.
The full GLP-1 family
When people say "Ozempic," they often mean GLP-1 medications generally. Here's the family:
- Ozempic (semaglutide) — FDA-approved for type 2 diabetes; commonly prescribed off-label for weight loss
- Wegovy (semaglutide, higher doses) — FDA-approved for weight management
- Mounjaro (tirzepatide) — FDA-approved for type 2 diabetes; works on both GLP-1 and GIP receptors
- Zepbound (tirzepatide) — FDA-approved for weight management
- Saxenda (liraglutide) — older, daily-injection GLP-1 for weight management
- Rybelsus (oral semaglutide) — pill form for type 2 diabetes
Eligibility criteria are similar across these medications. If you qualify for Ozempic for weight management, you generally also qualify for Wegovy, Zepbound, or Mounjaro under the appropriate indications.
The BMI thresholds in detail
BMI ≥ 30: You qualify on BMI alone
A BMI of 30 or higher is the clinical definition of obesity. At this level, almost all prescribing providers consider GLP-1 medication a reasonable option, regardless of whether you have any other health conditions.
This threshold reflects the strong evidence that obesity itself is a chronic disease with serious health consequences (cardiovascular disease, certain cancers, joint problems, etc.) and that pharmacological treatment is appropriate when lifestyle interventions alone haven't produced sufficient results.
If your BMI is 30+, the question isn't usually "do I qualify" but rather "is GLP-1 the right approach for me specifically" — a question that depends on your medical history, other medications, lifestyle, and personal preferences.
BMI 27–29.9: You qualify with a condition
The 27–29.9 range is officially the "overweight" category. At this BMI, you qualify for weight-management GLP-1 prescribing if you have at least one of these weight-related comorbidities:
- Type 2 diabetes
- Prediabetes (HbA1c 5.7–6.4% or fasting glucose 100–125)
- Hypertension (high blood pressure)
- Dyslipidemia (high cholesterol, high triglycerides, or low HDL)
- Obstructive sleep apnea
- Cardiovascular disease (heart attack, stroke, coronary artery disease)
- Non-alcoholic fatty liver disease (NAFLD or MASLD)
- Polycystic ovary syndrome (PCOS) with metabolic features
- Osteoarthritis in weight-bearing joints
Only one of these is needed. The presence of more strengthens the case but doesn't change the basic eligibility.
BMI 25–26.9: Borderline
The 25–26.9 range is "overweight" but below the standard threshold for GLP-1 prescribing. Most providers won't prescribe at this BMI without significant clinical justification — for example, a strong family history of metabolic disease combined with multiple borderline lab values.
If you're in this range, the most productive approach is usually:
- Get screened for sleep apnea (commonly undiagnosed)
- Check your fasting glucose and HbA1c (prediabetes can develop quietly)
- Verify your blood pressure across multiple readings
- Address lifestyle factors with a structured plan
Some of these screenings may reveal a qualifying comorbidity. Others may simply give you a clearer picture of your metabolic health.
BMI under 25: Does not qualify
BMI 18.5–24.9 is the "healthy weight" range. GLP-1 medications are not appropriate at this BMI for weight loss because the side-effect and risk profile outweighs the potential benefits when you're already at a healthy weight.
If you're at a healthy BMI but unhappy with your body composition, the better tools are usually body fat percentage measurement, strength training, and structured nutrition — not weight-loss medication.
What providers actually look at beyond BMI
BMI is the screening threshold, but real prescribing decisions involve a more complete picture. Providers also evaluate:
Medical history and contraindications
GLP-1 medications carry a boxed warning for thyroid C-cell tumors based on animal studies. Personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN-2) is an absolute contraindication.
Other histories that prompt caution or disqualification:
- Pancreatitis (especially recurrent)
- Severe gastrointestinal disease (gastroparesis, severe IBD)
- Active gallbladder disease
- Severe kidney impairment
- Pregnancy or planning pregnancy
- History of eating disorders (case-by-case)
Current medications
GLP-1 medications can affect the absorption of other oral medications by slowing stomach emptying. Providers typically review your complete medication list to check for interactions and may adjust dosing of medications like:
- Insulin and other diabetes medications (risk of low blood sugar)
- Oral contraceptives (potential absorption issues at high GLP-1 doses)
- Time-sensitive medications (anti-epileptics, warfarin)
Prior weight-loss attempts
Most FDA labels and clinical guidelines specify that GLP-1 medications should be added to a comprehensive weight-management plan that includes diet and exercise. In practice, most providers require some history of attempting weight loss without medication. This doesn't need to be a structured medical program — having tried various diets, exercise routines, or weight-loss programs over time is usually sufficient.
Realistic expectations
Providers want to know whether you understand that GLP-1 medications are typically a long-term commitment. Weight regain after stopping is common — multiple studies show patients regain roughly two-thirds of lost weight within a year of stopping. A provider who senses you're looking for a "quick fix" with no intent to make lifestyle changes will sometimes recommend against starting.
What if I'm borderline but want to try?
If your BMI is 27–29.9 and you're not sure you have a qualifying condition, the most productive steps are:
- Get a full metabolic panel from your primary care doctor. Sleep apnea, prediabetes, and dyslipidemia are very common and often undiagnosed at this BMI.
- Document your weight history. If you've struggled to maintain weight loss in the past, that history is relevant to a prescriber.
- Use our eligibility quiz to see how your specific profile maps to provider criteria.
- Consult a telehealth provider that specializes in weight management — they have more flexibility than general primary care.
Take the 30-second eligibility quiz
Get a clear answer based on your BMI and health profile — no email required.
Check my eligibility →How much will it cost?
GLP-1 medications are not cheap, and pricing varies dramatically by source:
- Brand-name Wegovy or Ozempic (US pharmacy, no insurance): $900–$1,300/month
- Brand-name with commercial insurance coverage: $25–$100/month copay (when covered)
- Compounded semaglutide via telehealth: $150–$300/month (cash-pay)
- Compounded tirzepatide via telehealth: $250–$400/month (cash-pay)
- Manufacturer savings programs (Novo Nordisk NovoCare): Can reduce branded copays to $0 in some cases for eligible commercially insured patients
Telehealth providers offering compounded versions have become extremely popular because they bypass the insurance approval process and offer transparent monthly pricing. The trade-off is that compounded medications are not FDA-approved as a finished drug product — they're prepared by compounding pharmacies on a per-patient basis.
Insurance reality check
Insurance coverage for GLP-1 medications is a mess. Here's the honest picture:
- Most insurance plans cover Ozempic only for type 2 diabetes
- Coverage for Wegovy and Zepbound (weight-loss indications) varies dramatically — some plans cover, many don't
- Plans that do cover often require step therapy (trying cheaper options first) or prior authorization
- Medicare currently does not cover GLP-1s for weight loss alone (only for diabetes)
- Medicaid coverage varies by state
Before pursuing GLP-1 through insurance, call your plan's pharmacy benefits line and specifically ask: "Is Wegovy (or Zepbound) covered for weight management on my plan? What are the requirements?" Don't rely on what your doctor's office tells you about coverage — they often have outdated information.
What to do next
If you're reading this article, you probably have a sense of whether you're likely to qualify. Here's the simplest decision tree:
- BMI ≥ 30: You qualify. Decide whether you want to pursue this with your primary care doctor (insurance pathway) or a telehealth provider (cash-pay or compounded).
- BMI 27–29.9 with a known condition: You qualify. Same decision tree as above.
- BMI 27–29.9 without a known condition: Get screened. You may have an undiagnosed condition that qualifies you. Sleep apnea screening and a metabolic panel are the highest-yield tests.
- BMI 25–26.9: GLP-1 is unlikely to be appropriate at this BMI. Focus on lifestyle approaches and address any underlying metabolic concerns.
- BMI under 25: GLP-1 isn't for you. If you're unhappy with body composition, body recomposition (strength training + protein) is the right tool.
Common questions
What BMI do I need to qualify for Ozempic?+
For weight management specifically, providers typically prescribe Ozempic (or its weight-loss labeled equivalent Wegovy) at BMI ≥ 30, or at BMI ≥ 27 if you also have at least one weight-related health condition like type 2 diabetes, high blood pressure, or sleep apnea. For type 2 diabetes management, Ozempic can be prescribed at any BMI when clinically indicated.
Can I get Ozempic without diabetes?+
Yes. Ozempic is FDA-approved for type 2 diabetes, but it can be prescribed off-label for weight loss. More commonly, providers prescribe Wegovy (the same active ingredient, semaglutide, at a higher dose) which is FDA-approved specifically for chronic weight management at BMI ≥ 30, or ≥ 27 with a comorbidity.
Will insurance cover Ozempic for weight loss?+
It depends. Most insurance plans cover Ozempic only when prescribed for type 2 diabetes. Coverage for Wegovy (weight-loss indication) varies widely — some plans cover it, many don't, and others require step therapy or prior authorization. Medicare currently does not cover GLP-1 medications for weight loss alone. Telehealth providers often use cash-pay or compounded options to bypass insurance.
How much does Ozempic cost without insurance?+
Brand-name Ozempic costs approximately $900–$1,200 per month at US pharmacies without insurance. Compounded semaglutide through telehealth providers ranges from $150–$300/month. Manufacturer savings programs (Novo Nordisk's NovoCare) can reduce out-of-pocket costs for eligible patients with commercial insurance.
Can I take Ozempic if I have prediabetes?+
Possibly. Prediabetes itself doesn't automatically qualify you, but if your BMI is ≥27 and you have prediabetes plus another condition (or BMI ≥30 alone), you would generally qualify under weight-loss indications. Many providers consider prediabetes a meaningful clinical factor when evaluating GLP-1 candidacy.
What if my BMI is 26?+
BMI 26 is technically in the "overweight" range but below the typical clinical threshold for GLP-1 prescription. Most providers will not prescribe at BMI 26 without significant clinical justification. Lifestyle interventions, a TDEE-based eating plan, and addressing any underlying metabolic issues are typically the first-line approach at this BMI.
Do I need to have tried diet and exercise first?+
Officially, yes — both FDA labels and most clinical guidelines recommend lifestyle intervention before GLP-1 therapy. In practice, telehealth providers vary in how strictly they enforce this. A history of unsuccessful weight loss attempts is usually sufficient documentation.
What disqualifies me from taking Ozempic?+
Absolute contraindications include personal or family history of medullary thyroid carcinoma (MTC), Multiple Endocrine Neoplasia syndrome type 2 (MEN-2), known hypersensitivity to semaglutide, and pregnancy or planned pregnancy. Relative contraindications that providers consider carefully include severe gastrointestinal disease, history of pancreatitis, severe kidney disease, and active gallbladder disease.
One last honest note
We built mybmi.ai because the existing landscape of "do I qualify for Ozempic" content was full of marketing dressed up as information. Telehealth providers wanted to qualify you regardless of fit. Pharmaceutical sites wanted to drive prescriptions for their specific brand. Affiliate sites wanted you to click anything.
We make money through affiliate partnerships with telehealth providers — that's public on every page with an affiliate link. But our eligibility logic is based on actual FDA-aligned clinical thresholds, not on what generates the most commission. A BMI 24 user sees "you don't qualify" no matter what.
If you've made it this far, you're taking your health seriously. The next step is to use the eligibility quiz, talk to a qualified provider, and make the decision that's right for your situation.
Medical disclaimer: This article is for educational purposes only and does not constitute medical advice. Always consult a licensed healthcare provider before starting any medication. Eligibility shown on mybmi.ai does not guarantee that any provider will prescribe medication to you. See our full medical disclaimer.